TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
META_PWY-6000	gamma-linolenate biosynthesis II (animals)	0.0159612431361871	-4.13759179925526	3	2	0.0294117647058824	68	903	9415,2180	FADS2,ACSL1
META_PWY-7724	icosapentaenoate biosynthesis III (8-desaturase, mammals)	0.0159612431361871	-4.13759179925526	3	2	0.0294117647058824	68	903	9415,2180	FADS2,ACSL1
META_PWY-7049	icosapentaenoate biosynthesis II (6-desaturase, mammals)	0.0159612431361871	-4.13759179925526	3	2	0.0294117647058824	68	903	9415,2180	FADS2,ACSL1
META_PWY-7426	mannosyl-glycoprotein N-acetylglucosaminyltransferases	0.0173987326404423	-4.05135791217057	8	3	0.0441176470588235	68	903	4124,4245,11282	MAN2A1,MGAT1,MGAT4B
META_PWY-6564	heparan sulfate biosynthesis	0.0241960104262824	-3.72156751782822	23	5	0.0735294117647059	68	903	27087,26229,2137,2134,2132	B3GAT1,B3GAT3,EXTL3,EXTL1,EXT2
META_PWY-7592	arachidonate biosynthesis III (6-desaturase, mammals)	0.0303723025267672	-3.49422418696802	4	2	0.0294117647058824	68	903	2180,9415	ACSL1,FADS2
HUMAN_THIOREDOX-PWY	thioredoxin pathway	0.0303723025267672	-3.49422418696802	4	2	0.0294117647058824	68	903	7296,10587	TXNRD1,TXNRD2
META_PWY-5189	tetrapyrrole biosynthesis II (from glycine)	0.0481763996305421	-3.03288601205668	5	2	0.0294117647058824	68	903	212,3145	ALAS2,HMBS
HUMAN_PWY-5189	tetrapyrrole biosynthesis	0.0481763996305421	-3.03288601205668	5	2	0.0294117647058824	68	903	212,3145	ALAS2,HMBS
HUMAN_PWY-6571	dermatan sulfate biosynthesis	0.0549579493161036	-2.90118694406213	12	3	0.0441176470588235	68	903	26229,27087,55790	B3GAT3,B3GAT1,CSGALNACT1
META_PWY-7277	sphingolipid biosynthesis (mammals)	0.0687958439378635	-2.67661194374736	6	2	0.0294117647058824	68	903	9517,2531	SPTLC2,KDSR
META_PWY3DJ-12	ceramide de novo biosynthesis	0.0687958439378635	-2.67661194374736	6	2	0.0294117647058824	68	903	9517,2531	SPTLC2,KDSR
META_PWY-5972	stearate biosynthesis I (animals and fungi)	0.0687958439378635	-2.67661194374736	6	2	0.0294117647058824	68	903	79071,2180	ELOVL6,ACSL1
META_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.0687958439378635	-2.67661194374736	6	2	0.0294117647058824	68	903	26229,27087	B3GAT3,B3GAT1
HUMAN_PWY3DJ-12	ceramide de novo biosynthesis	0.0687958439378635	-2.67661194374736	6	2	0.0294117647058824	68	903	2531,9517	KDSR,SPTLC2
HUMAN_PWY-6557	glycoaminoglycan-protein linkage region biosynthesis	0.0687958439378635	-2.67661194374736	6	2	0.0294117647058824	68	903	26229,27087	B3GAT3,B3GAT1
HUMAN_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	9054	NFS1
META_PWY-6241	thyroid hormone biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	1509	CTSD
HUMAN_PWY66-366	flavin biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	80308	FLAD1
META_PWY0-1021	L-alanine biosynthesis III	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	9054	NFS1
META_ALANINE-DEG3-PWY	L-alanine degradation III	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	2875	GPT
HUMAN_PWY-66	GDP-L-fucose biosynthesis I (from GDP-D-mannose)	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	7264	TSTA3
META_PWY-7250	[2Fe-2S] iron-sulfur cluster biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	9054	NFS1
HUMAN_ALANINE-DEG3-PWY	alanine biosynthesis/degradation	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	2875	GPT
META_PWY-5329	L-cysteine degradation III	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	2805	GOT1
META_PWY-7725	arachidonate biosynthesis V (8-detaturase, mammals)	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	9415	FADS2
HUMAN_PROUT-PWY	proline degradation	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	8659	ALDH4A1
META_ASPARTATESYN-PWY	L-aspartate biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	2805	GOT1
HUMAN_ARGSPECAT-PWY	spermine biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	6611	SMS
META_ALANINE-SYN2-PWY	L-alanine biosynthesis II	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	2875	GPT
META_ARGSPECAT-PWY	spermine biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	6611	SMS
HUMAN_PWY-6173	histamine biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	3067	HDC
HUMAN_PWY-5329	L-cysteine degradation II	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	2805	GOT1
META_PWY-6173	histamine biosynthesis	0.0753045404209335	-2.58621484823936	1	1	0.0147058823529412	68	903	3067	HDC
META_PWY-6571	dermatan sulfate biosynthesis	0.0967104631823791	-2.33603367986985	15	3	0.0441176470588235	68	903	55790,27087,26229	CSGALNACT1,B3GAT1,B3GAT3
HUMAN_PWY-6564	heparan sulfate biosynthesis	0.11190667972841	-2.19008997171565	25	4	0.0588235294117647	68	903	27087,2137,26229,2134	B3GAT1,EXTL3,B3GAT3,EXTL1
HUMAN_PWY-6569	chondroitin sulfate biosynthesis	0.112835880600829	-2.18182090006533	16	3	0.0441176470588235	68	903	27087,26229,55790	B3GAT1,B3GAT3,CSGALNACT1
META_PWY-5920	superpathway of heme biosynthesis from glycine	0.116491885664741	-2.14993365934855	8	2	0.0294117647058824	68	903	3145,212	HMBS,ALAS2
HUMAN_PWY-5920	heme biosynthesis	0.116491885664741	-2.14993365934855	8	2	0.0294117647058824	68	903	3145,212	HMBS,ALAS2
META_LEU-DEG2-PWY	L-leucine degradation I	0.116491885664741	-2.14993365934855	8	2	0.0294117647058824	68	903	56922,1738	MCCC1,DLD
META_PWY-6558	heparan sulfate biosynthesis (late stages)	0.129914435109585	-2.04087923669438	17	3	0.0441176470588235	68	903	2137,2132,2134	EXTL3,EXT2,EXTL1
HUMAN_PWY-6118	glycerol-3-phosphate shuttle	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2820	GPD2
META_PWY-6118	glycerol-3-phosphate shuttle	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2820	GPD2
META_PWY-5670	epoxysqualene biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	6713	SQLE
META_PWY-6124	inosine-5'-phosphate biosynthesis II	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	10606	PAICS
HUMAN_PWY-6241	thyroid hormone biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	1509	CTSD
HUMAN_PWY-5670	epoxysqualene biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	6713	SQLE
HUMAN_PWY-6124	inosine-5'-phosphate biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	10606	PAICS
HUMAN_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2618	GART
META_PWY-6121	5-aminoimidazole ribonucleotide biosynthesis I	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2618	GART
HUMAN_CYSTEINE-DEG-PWY	L-cysteine degradation I	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2805	GOT1
META_PWY-4041	gamma-glutamyl cycle	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2729	GCLC
META_PWY66-366	flavin biosynthesis IV (mammalian)	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	80308	FLAD1
HUMAN_ASPARTATESYN-PWY	aspartate biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2805	GOT1
META_PROSYN-PWY	L-proline biosynthesis I	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	5831	PYCR1
HUMAN_ASPARAGINE-BIOSYNTHESIS	asparagine biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2805	GOT1
HUMAN_PROSYN-PWY	proline biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	5831	PYCR1
HUMAN_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2618	GART
META_PWY-6613	tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2618	GART
META_PROUT-PWY	L-proline degradation	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	8659	ALDH4A1
HUMAN_PWY-6566	chondroitin biosynthesis	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	55790	CSGALNACT1
META_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.145015506329234	-1.93091460207764	2	1	0.0147058823529412	68	903	2673	GFPT1
META_PWY-6569	chondroitin sulfate biosynthesis	0.147850130013859	-1.91155615332077	18	3	0.0441176470588235	68	903	55790,27087,26229	CSGALNACT1,B3GAT1,B3GAT3
HUMAN_PWY-7049	icosapentaenoate biosynthesis II (metazoa)	0.170040892041193	-1.77171632943854	10	2	0.0294117647058824	68	903	2180,9415	ACSL1,FADS2
META_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.198157568269873	-1.61869276542521	11	2	0.0294117647058824	68	903	10682,6713	EBP,SQLE
META_PWY66-341	cholesterol biosynthesis I	0.198157568269873	-1.61869276542521	11	2	0.0294117647058824	68	903	10682,6713	EBP,SQLE
HUMAN_PWY-5972	stearate biosynthesis	0.198157568269873	-1.61869276542521	11	2	0.0294117647058824	68	903	2180,79071	ACSL1,ELOVL6
META_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.198157568269873	-1.61869276542521	11	2	0.0294117647058824	68	903	10682,6713	EBP,SQLE
HUMAN_GLYCLEAV-PWY	glycine cleavage	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	1738	DLD
META_GLYCINE-SYN2-PWY	glycine biosynthesis II	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	1738	DLD
META_ARGASEDEG-PWY	L-arginine degradation I (arginase pathway)	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	8659	ALDH4A1
META_PWY-6100	L-carnitine biosynthesis	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	8424	BBOX1
HUMAN_PWY0-1264	biotin-carboxyl carrier protein assembly	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	31	ACACA
META_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	1738	DLD
HUMAN_NAD-BIOSYNTHESIS-III	NAD salvage	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	10135	NAMPT
META_ASPARAGINE-DEG1-PWY-1	L-asparagine degradation III (mammalian)	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	2805	GOT1
META_GLYCLEAV-PWY	glycine cleavage	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	1738	DLD
META_PWY-7728	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase)	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	9415	FADS2
HUMAN_PWY-6100	L-carnitine biosynthesis	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	8424	BBOX1
HUMAN_PWY-5084	2-oxoglutarate decarboxylation to succinyl-CoA	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	1738	DLD
META_PWY-7727	docosahexaenoate biosynthesis IV (4-desaturase, mammals)	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	9415	FADS2
META_MALATE-ASPARTATE-SHUTTLE-PWY	L-aspartate degradation II	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	2805	GOT1
HUMAN_PWY-7606	docosahexaenoate biosynthesis III (mammals)	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	9415	FADS2
META_PWY66-425	L-lysine degradation II (L-pipecolate pathway)	0.209542637928859	-1.56282803799435	3	1	0.0147058823529412	68	903	5831	PYCR1
HUMAN_PWY-6000	gamma-linolenate biosynthesis	0.226797492060701	-1.4836977651231	12	2	0.0294117647058824	68	903	9415,2180	FADS2,ACSL1
HUMAN_LEU-DEG2-PWY	leucine degradation	0.226797492060701	-1.4836977651231	12	2	0.0294117647058824	68	903	1738,56922	DLD,MCCC1
META_PWY66-5	superpathway of cholesterol biosynthesis	0.247016891145787	-1.39829855948671	23	3	0.0441176470588235	68	903	6713,3157,10682	SQLE,HMGCS1,EBP
HUMAN_PWY66-341	cholesterol biosynthesis I	0.25572670801154	-1.36364595156649	13	2	0.0294117647058824	68	903	6713,10682	SQLE,EBP
HUMAN_PWY66-4	cholesterol biosynthesis III (via desmosterol)	0.25572670801154	-1.36364595156649	13	2	0.0294117647058824	68	903	6713,10682	SQLE,EBP
HUMAN_PWY66-3	cholesterol biosynthesis II (via 24,25-dihydrolanosterol)	0.25572670801154	-1.36364595156649	13	2	0.0294117647058824	68	903	6713,10682	SQLE,EBP
HUMAN_PWY-5328	superpathway of methionine degradation	0.25572670801154	-1.36364595156649	13	2	0.0294117647058824	68	903	2805,1738	GOT1,DLD
META_PWY-5328	superpathway of L-methionine salvage and degradation	0.25572670801154	-1.36364595156649	13	2	0.0294117647058824	68	903	1738,2805	DLD,GOT1
META_PWY-841	superpathway of purine nucleotides de novo biosynthesis I	0.25572670801154	-1.36364595156649	13	2	0.0294117647058824	68	903	2618,10606	GART,PAICS
HUMAN_HYDROXYPRODEG-PWY	4-hydroxyproline degradation	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	8659	ALDH4A1
HUMAN_MALATE-ASPARTATE-SHUTTLE-PWY	malate-aspartate shuttle	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	2805	GOT1
HUMAN_PWY-6755	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	55256	ADI1
HUMAN_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	55256	ADI1
HUMAN_PWY-4261	glycerol degradation	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	2820	GPD2
META_PWY66-368	ketolysis	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	56898	BDH2
META_POLYAMINSYN3-PWY	superpathway of polyamine biosynthesis II	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	6611	SMS
HUMAN_PWY-6823	molybdenum cofactor biosynthesis	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	9054	NFS1
HUMAN_ASPARAGINE-DEG1-PWY-1	asparagine degradation	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	2805	GOT1
HUMAN_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	1738	DLD
META_PWY-5046	2-oxoisovalerate decarboxylation to isobutanoyl-CoA	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	1738	DLD
META_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	55191	NADSYN1
META_HYDROXYPRODEG-PWY	trans-4-hydroxy-L-proline degradation I	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	8659	ALDH4A1
HUMAN_PWY-6517	N-acetylglucosamine degradation II	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	55577	NAGK
HUMAN_PWY-5653	NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	55191	NADSYN1
META_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	1738	DLD
HUMAN_PWY66-425	lysine degradation II (pipecolate pathway)	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	5831	PYCR1
HUMAN_PWY66-368	ketolysis	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	56898	BDH2
META_PWY-6823	molybdenum cofactor biosynthesis	0.269266083063717	-1.3120552319024	4	1	0.0147058823529412	68	903	9054	NFS1
HUMAN_FAO-PWY	fatty acid beta-oxidation	0.284742603260612	-1.25616965324996	14	2	0.0294117647058824	68	903	3032,2180	HADHB,ACSL1
META_FAO-PWY	fatty acid beta-oxidation I	0.284742603260612	-1.25616965324996	14	2	0.0294117647058824	68	903	3032,2180	HADHB,ACSL1
HUMAN_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.289399235114805	-1.23994810779168	25	3	0.0441176470588235	68	903	50614,442117,56913	GALNT9,GALNTL6,C1GALT1
HUMAN_PWY66-5	superpathway of cholesterol biosynthesis	0.289399235114805	-1.23994810779168	25	3	0.0441176470588235	68	903	3157,10682,6713	HMGCS1,EBP,SQLE
META_PWY-7726	(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis (6-desaturase)	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	9415	FADS2
META_PWY-6111	mitochondrial L-carnitine shuttle	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	1376	CPT2
META_PWY-6398	melatonin degradation I	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	1545	CYP1B1
META_PWY-6402	superpathway of melatonin degradation	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	1545	CYP1B1
HUMAN_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	7084	TK2
META_VALDEG-PWY	L-valine degradation I	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	1738	DLD
HUMAN_PWY-6111	mitochondrial L-carnitine shuttle	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	1376	CPT2
HUMAN_PYRUVDEHYD-PWY	pyruvate decarboxylation to acetyl CoA	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	1738	DLD
HUMAN_PWY-5966-1	fatty acid biosynthesis initiation	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	31	ACACA
META_PWY-7433	mucin core 1 and core 2 O-glycosylation	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	56913	C1GALT1
META_PWY-7199	pyrimidine deoxyribonucleosides salvage	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	7084	TK2
HUMAN_PWY66-367	ketogenesis	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	56898	BDH2
META_PWY-6566	chondroitin biosynthesis	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	55790	CSGALNACT1
HUMAN_UDPNACETYLGALSYN-PWY	UDP-N-acetyl-D-glucosamine biosynthesis II	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	2673	GFPT1
META_PWY-7606	docosahexaenoate biosynthesis III (6-desaturase, mammals)	0.324538503922599	-1.12535109372115	5	1	0.0147058823529412	68	903	9415	FADS2
HUMAN_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.370687551549316	-0.992395750319122	17	2	0.0294117647058824	68	903	8897,51259	MTMR3,TMEM216
META_PWY-5130	2-oxobutanoate degradation I	0.375687035920217	-0.978998833464924	6	1	0.0147058823529412	68	903	1738	DLD
META_ILEUDEG-PWY	L-isoleucine degradation I	0.375687035920217	-0.978998833464924	6	1	0.0147058823529412	68	903	1738	DLD
HUMAN_PWY-5130	2-oxobutanoate degradation	0.375687035920217	-0.978998833464924	6	1	0.0147058823529412	68	903	1738	DLD
HUMAN_PWY66-428	threonine degradation	0.375687035920217	-0.978998833464924	6	1	0.0147058823529412	68	903	1738	DLD
HUMAN_PWY-5143	fatty acid activation	0.375687035920217	-0.978998833464924	6	1	0.0147058823529412	68	903	2180	ACSL1
META_PWY66-367	ketogenesis	0.375687035920217	-0.978998833464924	6	1	0.0147058823529412	68	903	3157	HMGCS1
META_PWY66-428	L-threonine degradation V	0.375687035920217	-0.978998833464924	6	1	0.0147058823529412	68	903	1738	DLD
META_PWY66-374	C20 prostanoid biosynthesis	0.423015109006185	-0.860347381883013	7	1	0.0147058823529412	68	903	10728	PTGES3
HUMAN_PWY66-374	C20 prostanoid biosynthesis	0.423015109006185	-0.860347381883013	7	1	0.0147058823529412	68	903	10728	PTGES3
META_PWY-6872	retinoate biosynthesis I	0.423015109006185	-0.860347381883013	7	1	0.0147058823529412	68	903	220	ALDH1A3
HUMAN_PWY-6558	heparan sulfate biosynthesis (late stages)	0.425835925388187	-0.853701158573644	19	2	0.0294117647058824	68	903	2134,2137	EXTL1,EXTL3
HUMAN_PWY-6368	3-phosphoinositide degradation	0.452494964197348	-0.792978644749722	20	2	0.0294117647058824	68	903	93492,8897	TPTE2,MTMR3
HUMAN_PWY-6872	retinoate biosynthesis I	0.466804140912382	-0.761845507759934	8	1	0.0147058823529412	68	903	220	ALDH1A3
HUMAN_PWY-2201	folate transformations I	0.466804140912382	-0.761845507759934	8	1	0.0147058823529412	68	903	10840	ALDH1L1
META_NADSYN-PWY	NAD biosynthesis II (from tryptophan)	0.507315111213289	-0.678622947324473	9	1	0.0147058823529412	68	903	55191	NADSYN1
HUMAN_PWY3DJ-11470	sphingosine and sphingosine-1-phosphate metabolism	0.507315111213289	-0.678622947324473	9	1	0.0147058823529412	68	903	8877	SPHK1
HUMAN_MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS	dolichyl-diphosphooligosaccharide biosynthesis	0.507315111213289	-0.678622947324473	9	1	0.0147058823529412	68	903	1798	DPAGT1
META_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.507315111213289	-0.678622947324473	9	1	0.0147058823529412	68	903	1635	DCTD
META_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis I	0.507315111213289	-0.678622947324473	9	1	0.0147058823529412	68	903	1854	DUT
META_PWY-6367	D-myo-inositol-5-phosphate metabolism	0.507315111213289	-0.678622947324473	9	1	0.0147058823529412	68	903	8897	MTMR3
HUMAN_PWY-7527	methionine salvage cycle III	0.507315111213289	-0.678622947324473	9	1	0.0147058823529412	68	903	55256	ADI1
HUMAN_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	0.528126722107005	-0.638419020081686	23	2	0.0294117647058824	68	903	51259,8396	TMEM216,PIP4K2B
META_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.54479002445503	-0.60735483478615	10	1	0.0147058823529412	68	903	7084	TK2
HUMAN_PWY-6398	melatonin degradation I	0.54479002445503	-0.60735483478615	10	1	0.0147058823529412	68	903	1545	CYP1B1
HUMAN_PWY-922	mevalonate pathway	0.54479002445503	-0.60735483478615	10	1	0.0147058823529412	68	903	3157	HMGCS1
META_PWY-922	mevalonate pathway I	0.54479002445503	-0.60735483478615	10	1	0.0147058823529412	68	903	3157	HMGCS1
HUMAN_PWY-6402	superpathway of melatonin degradation	0.579453270074276	-0.545670257807054	11	1	0.0147058823529412	68	903	1545	CYP1B1
HUMAN_NADSYN-PWY	NAD de novo biosynthesis	0.579453270074276	-0.545670257807054	11	1	0.0147058823529412	68	903	55191	NADSYN1
HUMAN_ILEUDEG-PWY	isoleucine degradation	0.611512886258151	-0.491819250882914	12	1	0.0147058823529412	68	903	1738	DLD
HUMAN_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.611512886258151	-0.491819250882914	12	1	0.0147058823529412	68	903	3157	HMGCS1
META_PWY66-391	fatty acid beta-oxidation VI (peroxisome)	0.611512886258151	-0.491819250882914	12	1	0.0147058823529412	68	903	2180	ACSL1
HUMAN_VALDEG-PWY	valine degradation	0.611512886258151	-0.491819250882914	12	1	0.0147058823529412	68	903	1738	DLD
META_PWY-5910	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	0.611512886258151	-0.491819250882914	12	1	0.0147058823529412	68	903	3157	HMGCS1
META_PWY-6857	retinol biosynthesis	0.611512886258151	-0.491819250882914	12	1	0.0147058823529412	68	903	9227	LRAT
META_PWY-6861	the visual cycle I (vertebrates)	0.641161734446732	-0.444473538058217	13	1	0.0147058823529412	68	903	9227	LRAT
HUMAN_PWY66-391	fatty acid beta-oxidation (peroxisome)	0.641161734446732	-0.444473538058217	13	1	0.0147058823529412	68	903	2180	ACSL1
META_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.641161734446732	-0.444473538058217	13	1	0.0147058823529412	68	903	1854	DUT
HUMAN_PWY-7184	pyrimidine deoxyribonucleotides de novo biosynthesis	0.668578590692102	-0.40260132660948	14	1	0.0147058823529412	68	903	1854	DUT
HUMAN_PWY-7210	pyrimidine deoxyribonucleotides biosynthesis from CTP	0.668578590692102	-0.40260132660948	14	1	0.0147058823529412	68	903	1635	DCTD
HUMAN_PWY66-400	glycolysis	0.693929159685317	-0.365385399066766	15	1	0.0147058823529412	68	903	5315	PKM
HUMAN_PWY-6861	the visual cycle I (vertebrates)	0.693929159685317	-0.365385399066766	15	1	0.0147058823529412	68	903	9227	LRAT
HUMAN_PWY-7200	superpathway of pyrimidine deoxyribonucleoside salvage	0.693929159685317	-0.365385399066766	15	1	0.0147058823529412	68	903	7084	TK2
META_ANAEROFRUCAT-PWY	homolactic fermentation	0.693929159685317	-0.365385399066766	15	1	0.0147058823529412	68	903	5315	PKM
META_ANAGLYCOLYSIS-PWY	glycolysis III (from glucose)	0.693929159685317	-0.365385399066766	15	1	0.0147058823529412	68	903	5315	PKM
HUMAN_PWY66-401	superpathway of tryptophan utilization	0.710925837165413	-0.341187162403561	32	2	0.0294117647058824	68	903	1545,55191	CYP1B1,NADSYN1
HUMAN_PWY-6857	retinol biosynthesis	0.739034483408518	-0.302410696864779	17	1	0.0147058823529412	68	903	9227	LRAT
HUMAN_PWY66-407	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	0.771381904674214	-0.25957169125575	36	2	0.0294117647058824	68	903	5315,1738	PKM,DLD
META_PWY-6368	3-phosphoinositide degradation	0.777576079211313	-0.251573788640209	19	1	0.0147058823529412	68	903	8897	MTMR3
HUMAN_PWY-4061	glutathione-mediated detoxification	0.777576079211313	-0.251573788640209	19	1	0.0147058823529412	68	903	2947	GSTM3
HUMAN_PWY-841	purine nucleotides de novo biosynthesis	0.784697534105329	-0.242456942321687	37	2	0.0294117647058824	68	903	10606,2618	PAICS,GART
HUMAN_PWY-7211	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	0.794685611582814	-0.229808699670131	20	1	0.0147058823529412	68	903	1854	DUT
HUMAN_TRIGLSYN-PWY	triacylglycerol biosynthesis	0.862598306957276	-0.147806157490844	25	1	0.0147058823529412	68	903	8611	PLPP1
HUMAN_PWY-6352	3-phosphoinositide biosynthesis	0.883068501503437	-0.124352503240618	27	1	0.0147058823529412	68	903	8396	PIP4K2B
HUMAN_PWY-6371	superpathway of inositol phosphate compounds	0.891710028582166	-0.114614279316942	66	3	0.0441176470588235	68	903	8897,8396,51259	MTMR3,PIP4K2B,TMEM216
HUMAN_LIPASYN-PWY	phospholipases	0.900527220899997	-0.104774886172256	29	1	0.0147058823529412	68	903	51259	TMEM216
HUMAN_PWY-7511	protein ubiquitylation	0.900527220899997	-0.104774886172256	29	1	0.0147058823529412	68	903	79876	UBA5
META_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PROPIONMET-PWY	propanoyl CoA degradation I	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-7179-1	purine deoxyribonucleosides degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY6666-1	anandamide degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY3O-4106	NAD salvage pathway III	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6370	ascorbate recycling (cytosolic)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_CHOLINE-BETAINE-ANA-PWY	choline degradation I	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-5340	sulfate activation for sulfonation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-0	putrescine degradation III	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-5874	heme degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-5137	fatty acid beta-oxidation (unsaturated, odd number)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY66-397	resolvin D biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY66-14	MAP kinase cascade	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_LYSINE-DEG1-PWY	L-lysine degradation XI (mammalian)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6620	guanine and guanosine salvage	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY66-393	aspirin-triggered lipoxin biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-7179-1	purine deoxyribonucleosides degradation II	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_GLUTAMINDEG-PWY	glutamine degradation/glutamate biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-5453	methylglyoxal degradation III	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY0-1275	lipoate biosynthesis and incorporation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-2301	myo-inositol de novo biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-5525	D-glucuronate degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-5505	L-glutamate and L-glutamine biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-5269	cardiolipin biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY6666-2	dopamine degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-5905	hypusine biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY66-388	fatty acid alpha-oxidation III	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6260	thyroid hormone metabolism I (via deiodination)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6620	guanine and guanosine salvage	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-5806	all-trans-decaprenyl diphosphate biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6181	histamine degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY0-662	PRPP biosynthesis I	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-5030	L-histidine degradation III	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-5386	methylglyoxal degradation I	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-5177	glutaryl-CoA degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6129	dolichol and dolichyl phosphate biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-4041	gamma-glutamyl cycle	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-4821	UDP-D-xylose and UDP-D-glucuronate biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-5686	UMP biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_GLYSYN-ALA-PWY	glycine biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY66-397	resolvin D biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-7286	7-(3-amino-3-carboxypropyl)-wyosine biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-5481	lactate fermentation (reoxidation of cytosolic NADH)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6370	ascorbate recycling (cytosolic)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6145	superpathway of CMP-sialic acids biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6688	thyronamine and iodothyronamine metabolism	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6181	histamine degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY66-395	aspirin triggered resolvin D biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_SER-GLYSYN-PWY	superpathway of L-serine and glycine biosynthesis I	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-1801	formaldehyde oxidation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6012-1	acyl carrier protein metabolism	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-7343	UDP-glucose biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_GLUDEG-I-PWY	GABA shunt	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6482	diphthamide biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PROPIONMET-PWY	propionyl-CoA degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6	GDP-L-fucose biosynthesis II (from L-fucose)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_LYSINE-DEG1-PWY	lysine degradation I (saccharopine pathway)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6117	spermine and spermidine degradation I	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6365	D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY0-1295	pyrimidine ribonucleosides degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY66-394	aspirin triggered resolvin E biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6076	vitamin D3 biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY66-301	catecholamine biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_CHOLINE-BETAINE-ANA-PWY	choline degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PLPSAL-PWY	pyridoxal 5'-phosphate salvage I	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-6076	vitamin D3 biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY0-1182	trehalose degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-5340	sulfate activation for sulfonation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_BETA-ALA-DEGRADATION-I-PWY	beta-alanine degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_SERDEG-PWY	L-serine degradation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
META_PWY-7437	protein O-[N-acetyl]-glucosylation	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY-6138	CMP-N-acetylneuraminate biosynthesis I (eukaryotes)	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_PWY0-662	PRPP biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_GLYSYN-PWY	glycine/serine biosynthesis	0.999999999997921	-2.0794563987403e-12	2	0	0	68	903
HUMAN_GLNSYN-PWY	glutamine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6619	adenine and adenosine salvage VI	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY66-426	hydrogen sulfide biosynthesis (trans-sulfuration)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6938	NADH repair	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_MANNCAT-PWY	D-mannose degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_GLYCGREAT-PWY	creatine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-7219	adenosine ribonucleotides de novo biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-46	putrescine biosynthesis I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6481	L-dopachrome biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6133	(S)-reticuline biosynthesis II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-7592	arachidonate biosynthesis III (metazoa)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY0-1305	glutamate dependent acid resistance	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-4101	sorbitol degradation I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_BGALACT-PWY	lactose degradation III	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5120	geranylgeranyl diphosphate biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6012-1	acyl carrier protein activation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-5172	acetyl-CoA biosynthesis from citrate	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6399	melatonin degradation II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6405	Rapoport-Luebering glycolytic shunt	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY66-388	fatty acid alpha-oxidation III	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY66-11	BMP Signalling Pathway	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY66-241	bupropion degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_SERDEG-PWY	L-serine degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-1722	formate assimilation into 5,10-methylenetetrahydrofolate	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6377	alpha-tocopherol degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY66-421	homocarnosine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6898	thiamin salvage III	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5966	fatty acid biosynthesis initiation II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-7501	phosphatidylserine biosynthesis I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY66-421	homocarnosine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and dephosphorylation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5766	L-glutamate degradation X	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-7344	UDP-D-galactose biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_GLNSYN-PWY	L-glutamine biosynthesis I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-5326	sulfite oxidation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6292	superpathway of L-cysteine biosynthesis (mammalian)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_GLUT-REDOX-PWY	glutathione redox reactions II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6535	4-aminobutanoate degradation I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_P121-PWY	adenine and adenosine salvage I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6273	phosphatidylethanolamine biosynthesis III	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_GLUTAMATE-SYN2-PWY	L-glutamate biosynthesis II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6502	oxidized GTP and dGTP detoxification	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-2161B	glutamate removal from folates	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY0-522	lipoate salvage	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6938	NADH repair	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-5120	geranylgeranyldiphosphate biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-4361	S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-5148	acyl-CoA hydrolysis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-7435	mucin core 3 and core 4 O-glycosylation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-46	putrescine biosynthesis III	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_MGLDLCTANA-PWY	methylglyoxal degradation VI	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-7306	estradiol biosynthesis II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6756	S-methyl-5'-thioadenosine degradation II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6132	lanosterol biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY6666-1	anandamide degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_GLYCGREAT-PWY	creatine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6756	S-methyl-5'-thioadenosine degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-7506	phosphatidylserine biosynthesis II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6132	lanosterol biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-7501	phosphatidylserine biosynthesis I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_NADPHOS-DEPHOS-PWY-1	NAD phosphorylation and transhydrogenation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5686	UMP biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-5754	4-hydroxybenzoate biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6134	L-tyrosine biosynthesis IV	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY0-1313	acetate conversion to acetyl-CoA	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_SERSYN-PWY	serine biosynthesis (phosphorylated route)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6619	adenine and adenosine salvage II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-5652	2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5172	acetyl-CoA biosynthesis III (from citrate)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY66-420	carnosine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY66-380	estradiol biosynthesis I (via estrone)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-7112	4-hydroxy-2-nonenal detoxification	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5512	UDP-N-acetyl-D-galactosamine biosynthesis I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5326	sulfite oxidation IV	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6502	oxidized GTP and dGTP detoxification	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_HISHP-PWY	L-histidine degradation VI	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5754	4-hydroxybenzoate biosynthesis I (eukaryotes)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_HOMOCYSDEGR-PWY	cysteine biosynthesis/homocysteine degradation (trans-sulfuration)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_GLUTAMATE-SYN2-PWY	glutamate biosynthesis/degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5886	4-hydroxyphenylpyruvate biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_BSUBPOLYAMSYN-PWY	spermidine biosynthesis I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-5963	thio-molybdenum cofactor biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6481	L-dopachrome biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-40	putrescine biosynthesis II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_GLUT-REDOX-PWY	glutathione-glutaredoxin redox reactions	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_BSUBPOLYAMSYN-PWY	spermidine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5269	cardiolipin biosynthesis II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6334	L-dopa degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6535	4-aminobutyrate degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-40	putrescine biosynthesis I	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-6307	L-tryptophan degradation X (mammalian, via tryptamine)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY66-420	carnosine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6377	alpha-tocopherol degradation	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
HUMAN_PWY-6133	(S)-reticuline biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-7506	phosphatidylserine biosynthesis II	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-5905	hypusine biosynthesis	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY-7625	phosphatidylinositol biosynthesis II (eukaryotes)	0.999999999999843	-1.57443502679655e-13	1	0	0	68	903
META_PWY66-221	nicotine degradation V	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-162	ethanol degradation IV	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-5663	tetrahydrobiopterin de novo biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PHENYLALANINE-DEG1-PWY	phenylalanine degradation/tyrosine biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-6405	Rapoport-Luebering glycolytic shunt	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-161	oxidative ethanol degradation III	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY66-381	glucocorticoid biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-21	ethanol degradation II	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_METHIONINE-DEG1-PWY	methionine degradation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_OXIDATIVEPENT-PWY	pentose phosphate pathway (oxidative branch)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-7193	pyrimidine ribonucleosides salvage I	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY0-1296	purine ribonucleosides degradation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY66-387	fatty acid alpha-oxidation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-2301	myo-inositol biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-7511	protein ubiquitylation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PHENYLALANINE-DEG1-PWY	L-phenylalanine degradation I (aerobic)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_ARGININE-SYN4-PWY	L-ornithine biosynthesis II	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY6666-2	dopamine degradation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-3982	uracil degradation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-392	lipoxin biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_ADENOSYLHOMOCYSCAT-PWY	L-methionine salvage from L-homocysteine	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-6318	L-phenylalanine degradation IV (mammalian, via side chain)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-5663	tetrahydrobiopterin biosynthesis I	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY66-382	mineralocorticoid biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-6875	retinoate biosynthesis II	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-7527	L-methionine salvage cycle III	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-6609	adenine and adenosine salvage III	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-5661	GDP-glucose biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-7185	UTP and CTP dephosphorylation I	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-6430	thymine degradation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-5664	tetrahydrobiopterin biosynthesis II	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-6608	guanosine nucleotides degradation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-3982	uracil degradation I (reductive)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-422	D-galactose degradation V (Leloir pathway)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-7177	UTP and CTP dephosphorylation II	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-7466	acetone degradation III (to propane-1,2-diol)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-6609	adenine and adenosine salvage III	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-5996	oleate biosynthesis II (animals and fungi)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_OXIDATIVEPENT-PWY-1	pentose phosphate pathway (oxidative branch)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-7283	wybutosine biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-5331	taurine biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-387	fatty acid alpha-oxidation II	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY0-1296	purine ribonucleosides degradation to ribose-1-phosphate	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-7185	UTP and CTP dephosphorylation I	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY66-385	dTMP de novo biosynthesis (mitochondrial)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_ADENOSYLHOMOCYSCAT-PWY	methionine salvage	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-381	glucocorticoid biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_GLUDEG-I-PWY	GABA shunt	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-6366	D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_FASYN-ELONG-PWY	fatty acid elongation -- saturated	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_SAM-PWY	S-adenosyl-L-methionine biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-5453	methylglyoxal degradation III	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_HEME-BIOSYNTHESIS-II	heme biosynthesis I (aerobic)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-6307	tryptophan degradation via tryptamine	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_NONOXIPENT-PWY	pentose phosphate pathway (non-oxidative branch)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_HEME-BIOSYNTHESIS-II	heme biosynthesis from uroporphyrinogen-III I	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_GLUAMCAT-PWY	N-acetylglucosamine degradation I	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_ARGININE-SYN4-PWY	ornithine de novo  biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-4202	arsenate detoxification I (glutaredoxin)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-4202	arsenate detoxification I (glutaredoxin)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-6554	1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY0-1295	pyrimidine ribonucleosides degradation	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-5451	acetone degradation I (to methylglyoxal)	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-382	mineralocorticoid biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-5331	taurine biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-6158	creatine-phosphate biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY66-301	catecholamine biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY-5661-1	GDP-glucose biosynthesis II	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_2PHENDEG-PWY	phenylethylamine degradation I	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
HUMAN_PWY66-392	lipoxin biosynthesis	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-7193	pyrimidine ribonucleosides salvage I	1.00000000000012	1.17875707025122e-13	3	0	0	68	903
META_PWY-7209	superpathway of pyrimidine ribonucleosides degradation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY-3661-1	glycine betaine degradation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PLPSAL-PWY	pyridoxal 5'-phosphate salvage	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-4983	L-citrulline-nitric oxide cycle	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-4081	glutathione-peroxide redox reactions	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_COA-PWY-1	coenzyme A biosynthesis II (mammalian)	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-3661-1	glycine betaine degradation II (mammalian)	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_CITRULBIO-PWY	L-citrulline biosynthesis	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY4FS-6	phosphatidylethanolamine biosynthesis II	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-6074	zymosterol biosynthesis	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY66-201	nicotine degradation IV	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_TYRFUMCAT-PWY	tyrosine degradation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY-5030	histidine degradation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY-7180	2'-deoxy-alpha-D-ribose 1-phosphate degradation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY66-422	D-galactose degradation V (Leloir pathway)	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-5667	CDP-diacylglycerol biosynthesis I	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-4984	urea cycle	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY66-375	leukotriene biosynthesis	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY-7181	pyrimidine deoxyribonucleosides degradation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY-4983	citrulline-nitric oxide cycle	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_TYRFUMCAT-PWY	L-tyrosine degradation I	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_COA-PWY-1	coenzyme A biosynthesis	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY66-375	leukotriene biosynthesis	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY66-161	oxidative ethanol degradation III	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY66-378	androgen biosynthesis	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
HUMAN_PWY66-241	bupropion degradation	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis I	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-4921	protein citrullination	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-4061	glutathione-mediated detoxification I	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_SALVADEHYPOX-PWY	adenosine nucleotides degradation II	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-5651	L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY66-378	androgen biosynthesis	1.00000000000085	8.51151476400768e-13	5	0	0	68	903
META_PWY-5872	ubiquinol-10 biosynthesis (eukaryotic)	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-5067	glycogen biosynthesis II (from UDP-D-Glucose)	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-5874	heme degradation	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY66-21	ethanol degradation II	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-5659	GDP-mannose biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY66-162	ethanol degradation IV	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-4921	protein citrullination	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-5177	glutaryl-CoA degradation	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-2161	folate polyglutamylation	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY66-380	estradiol biosynthesis I	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-6313	serotonin degradation	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-6292	cysteine biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_SER-GLYSYN-PWY	serine and glycine biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY66-423	fructose 2,6-bisphosphate synthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-7177	UTP and CTP dephosphorylation II	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-7181	pyrimidine deoxyribonucleosides degradation	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-6568	dermatan sulfate biosynthesis (late stages)	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-7112	4-hydroxy-2-nonenal detoxification	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-6158	creatine-phosphate biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-6608	guanosine nucleotides degradation III	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-7434	terminal O-glycans residues modification	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-3781	aerobic respiration I (cytochrome c)	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-5123	trans, trans-farnesyl diphosphate biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-7205	CMP phosphorylation	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY66-423	fructose 2,6-bisphosphate biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-6875	retinoate biosynthesis II	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-6568	dermatan sulfate biosynthesis (late stages)	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-6030	serotonin and melatonin biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-6117	spermine and spermidine degradation I	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-6261	thyroid hormone metabolism II (via conjugation and/or degradation)	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-6061	bile acid biosynthesis, neutral pathway	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-5872	ubiquinol-10 biosynthesis	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY-5994	palmitate biosynthesis I (animals and fungi)	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-4984	urea cycle	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
META_PWY66-373	sucrose degradation V (sucrose alpha-glucosidase)	1.00000000000087	8.68969467508664e-13	4	0	0	68	903
HUMAN_PWY-5067	glycogen biosynthesis	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
HUMAN_PWY-5514	UDP-N-acetyl-D-galactosamine biosynthesis II	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
HUMAN_PWY66-414	superpathway of choline degradation to L-serine	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
META_DETOX1-PWY-1	reactive oxygen species degradation	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
META_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
HUMAN_PWY-5651	tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
HUMAN_PWY66-221	nicotine degradation III	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
HUMAN_PWY-6369	inositol pyrophosphates biosynthesis	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
HUMAN_PWY3DJ-11281	sphingomyelin metabolism/ceramide salvage	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
META_PWY-7224	purine deoxyribonucleosides salvage	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
META_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
META_PWY-6567	chondroitin sulfate biosynthesis (late stages)	1.00000000000166	1.66465347084365e-12	7	0	0	68	903
HUMAN_PWY-5996	oleate biosynthesis	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY-4081	glutathione redox reactions I	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY-7455	allopregnanolone biosynthesis	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
META_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY66-373	sucrose degradation	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
META_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY3O-450	phosphatidylcholine biosynthesis	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
META_PWY-7229	superpathway of adenosine nucleotides de novo biosynthesis I	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
META_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PENTOSE-P-PWY	pentose phosphate pathway	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
META_PWY-7455	allopregnanolone biosynthesis	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY-5695	urate biosynthesis/inosine 5'-phosphate degradation	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
META_PWY-5327	superpathway of L-lysine degradation	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY-6313	serotonin degradation	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY-7209	pyrimidine ribonucleosides degradation	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY-6074	zymosterol biosynthesis	1.00000000000249	2.4877670881996e-12	6	0	0	68	903
HUMAN_PWY-6567	chondroitin sulfate biosynthesis (late stages)	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
HUMAN_PWY-5994	palmitate biosynthesis	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
HUMAN_PWY-0	putrescine degradation III	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
HUMAN_SALVADEHYPOX-PWY	adenosine nucleotides degradation	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
HUMAN_PWY-7434	terminal O-glycans residues modification	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
HUMAN_TRYPTOPHAN-DEGRADATION-1	tryptophan degradation	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
META_PWY-7228	superpathway of guanosine nucleotides de novo biosynthesis I	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
HUMAN_PWY-5451	acetone degradation I (to methylglyoxal)	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
META_TRYPTOPHAN-DEGRADATION-1	L-tryptophan degradation III (eukaryotic)	1.00000000000284	2.84079120442322e-12	8	0	0	68	903
META_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000376	3.75982342768799e-12	9	0	0	68	903
META_PWY-6309	L-tryptophan degradation XI (mammalian, via kynurenine)	1.00000000000376	3.75982342768799e-12	9	0	0	68	903
HUMAN_PWY-6342	noradrenaline and adrenaline degradation	1.00000000000376	3.75982342768799e-12	9	0	0	68	903
META_PWY-6353	purine nucleotides degradation II (aerobic)	1.00000000000376	3.75982342768799e-12	9	0	0	68	903
HUMAN_PWY-7205	CMP phosphorylation	1.00000000000376	3.75982342768799e-12	9	0	0	68	903
HUMAN_PWY-7197	pyrimidine deoxyribonucleotide phosphorylation	1.00000000000416	4.15559976381587e-12	10	0	0	68	903
HUMAN_PWY66-201	nicotine degradation IV	1.00000000000416	4.15559976381587e-12	10	0	0	68	903
HUMAN_PWY-7227	adenosine deoxyribonucleotides de novo biosynthesis	1.00000000000416	4.15559976381587e-12	10	0	0	68	903
HUMAN_PWY-7226	guanosine deoxyribonucleotides de novo biosynthesis	1.00000000000416	4.15559976381587e-12	10	0	0	68	903
HUMAN_PWY-6353	purine nucleotides degradation	1.00000000000416	4.15559976381587e-12	10	0	0	68	903
HUMAN_DETOX1-PWY-1	reactive oxygen species degradation	1.00000000000416	4.15559976381587e-12	10	0	0	68	903
HUMAN_PWY-6309	L-kynurenine degradation	1.00000000000516	5.1595565523829e-12	11	0	0	68	903
META_PWY-5004	superpathway of L-citrulline metabolism	1.00000000000516	5.1595565523829e-12	11	0	0	68	903
HUMAN_PWY-7221	guanosine ribonucleotides de novo biosynthesis	1.00000000000516	5.1595565523829e-12	11	0	0	68	903
HUMAN_PWY-7224	purine deoxyribonucleosides salvage	1.00000000000516	5.1595565523829e-12	11	0	0	68	903
META_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	1.00000000000516	5.1595565523829e-12	11	0	0	68	903
HUMAN_LIPAS-PWY	triacylglycerol degradation	1.00000000000516	5.1595565523829e-12	11	0	0	68	903
HUMAN_PWY-7176	UTP and CTP de novo biosynthesis	1.00000000000516	5.1595565523829e-12	11	0	0	68	903
HUMAN_PWY-6061	bile acid biosynthesis, neutral pathway	1.00000000000552	5.52497949285439e-12	12	0	0	68	903
HUMAN_PWY-7305	superpathway of steroid hormone biosynthesis	1.00000000000552	5.52497949285439e-12	12	0	0	68	903
META_PWY-6351	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	1.00000000000695	6.95339877055544e-12	13	0	0	68	903
META_PWY66-409	superpathway of purine nucleotide salvage	1.00000000000695	6.95339877055544e-12	13	0	0	68	903
HUMAN_PWY0-162	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1.00000000000695	6.95339877055544e-12	13	0	0	68	903
HUMAN_PWY-6363	D-myo-inositol (1,4,5)-trisphosphate degradation	1.00000000000695	6.95339877055544e-12	13	0	0	68	903
HUMAN_PWY-7228	guanosine nucleotides de novo biosynthesis	1.00000000000764	7.64065052492304e-12	14	0	0	68	903
META_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	1.00000000000954	9.53793112472081e-12	15	0	0	68	903
META_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	1.00000000000954	9.53793112472081e-12	15	0	0	68	903
HUMAN_PWY-6364	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	1.00000000000954	9.53793112472081e-12	15	0	0	68	903
HUMAN_PWY66-399	gluconeogenesis	1.00000000000954	9.53793112472081e-12	15	0	0	68	903
HUMAN_PWY-6362	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	1.00000000000954	9.53793112472081e-12	15	0	0	68	903
META_PWY66-399	gluconeogenesis III	1.00000000000954	9.53793112472081e-12	15	0	0	68	903
HUMAN_PWY66-398	TCA cycle	1.00000000001012	1.01223356711841e-11	16	0	0	68	903
META_PWY66-398	TCA cycle III (animals)	1.00000000001012	1.01223356711841e-11	16	0	0	68	903
META_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	1.00000000001086	1.08608128712639e-11	19	0	0	68	903
HUMAN_PWY-7219	adenosine ribonucleotides de novo biosynthesis	1.00000000001086	1.08608128712639e-11	19	0	0	68	903
HUMAN_PWY-5667	CDP-diacylglycerol biosynthesis	1.00000000001086	1.08608128712639e-11	19	0	0	68	903
HUMAN_PWY-6358	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	1.0000000000133	1.33027793938816e-11	20	0	0	68	903
META_PWY-6352	3-phosphoinositide biosynthesis	1.00000000001689	1.68896914142895e-11	25	0	0	68	903
HUMAN_PWY66-409	superpathway of purine nucleotide salvage	1.00000000002476	2.47566998707038e-11	38	0	0	68	903
